Blood concentration of undercarboxylated osteocalcin (uc - OC) in hemodialysis patients using warfarin

Blood concentration of undercarboxylated osteocalcin (uc - OC) in hemodialysis patients using warfarin - Blood undercarboxylated osteocalcin (uc - OC) in hemodialysis patients using warfarin

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034633

Enrollment

Registered

2018-10-25

Start date

2018-10-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients in outpatient visit of Tsukinomori clinic, Kasukabe internal medicine clinic, or Koshigaya oobukuro clinic

Exclusion criteria

Exclusion criteria: Patients complicated with serious diseases such as cancer, hematological disorders, and liver cirrhosis

Design outcomes

Primary

Measure	Time frame
Difference in blood concentration of uc - OC, bone alkaline phosphatase (BAP), tartarate - resistant acid phosphatase - 5 b (TRACP - 5 b) in hemodialysis patients taking warfarin and those not taking	—

Countries

Japan

Contacts

Public ContactYasuyo Matsukura

Saitama Tsukinomori Clinic Pharmaceutical division

matsukura@k-naika-cl.jp048-792-1811

Outcome results